Fortrea Holdings FTRE
NASDAQ FTRE
$16.79 -0.27 (-1.58%)
As of: Sep 9, 2026 · 3:59 PM EDT

Fortrea Holdings (FTRE) EBITDA (2022 - 2026)

Fortrea Holdings' (FTRE) quarterly EBITDA came in at $14.8 million in Q2 2026, up 104.48% on a YoY basis from $7.2 million in Q2 2025, and up 535.29% quarter-over-quarter from -$3.4 million in Q1 2026.

Analysis

Fortrea Holdings (FTRE) EBITDA (2022 - 2026) Analysis & Trends

Fortrea Holdings (FTRE) has reported EBITDA for 5 consecutive years, with $14.8 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, EBITDA rose 104.48% year-over-year to $14.8 million; the trailing twelve-month figure through Jun 2026 stood at -$10.8 million (up 98.83% YoY), and the FY2025 full-year result was -$852.9 million, down 520.74% from the prior year.
  • EBITDA improved to $14.8 million in Q2 2026 per FTRE's latest filing, from -$3.4 million in the prior quarter.
  • Across five years, EBITDA topped out at $71.2 million in Q2 2022 and bottomed at -$520.1 million in Q1 2025.
  • Historically, EBITDA has averaged -$49.2 million across 5 years, with a median of -$8.6 million in 2025.
  • The sharpest annual moves came in 2025 and 2026: EBITDA sank 1290.64% in 2025, then jumped 104.48% in 2026.
  • Over 5 years, EBITDA stood at $14.3 million in 2022, then slumped by 267.83% to -$24.0 million in 2023, then tumbled by 131.67% to -$55.6 million in 2024, then surged by 75.54% to -$13.6 million in 2025, then jumped by 208.82% to $14.8 million in 2026.
  • According to Business Quant data, EBITDA over the past three periods registered $14.8 million, -$3.4 million, and -$13.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA (Qtr)
1 Iqvia Holdings 44.06 Bn 42.11 Bn 1.44 Bn 506.00 Mn
2 Medpace Holdings 16.50 Bn 16.00 Bn 201.64 Mn 153.38 Mn
3 Charles River Laboratories International 13.77 Bn 13.62 Bn 452.07 Mn 119.89 Mn
4 Icon 12.62 Bn 11.69 Bn 479.29 Mn 327.25 Mn
5 Fortrea Holdings 1.68 Bn 1.51 Bn 139.20 Mn 14.80 Mn
6 Evotec SE 661.34 Mn 235.46 Mn - -
7 Ginkgo Bioworks Holdings 442.79 Mn 358.26 Mn 18.44 Mn -58.55 Mn
8 Champions Oncology 72.49 Mn 72.62 Mn 7.03 Mn -522,000.00
9 MindWalk Holdings 61.66 Mn 53.38 Mn 1.82 Mn -2.33 Mn
10 VivoSim Labs 1.47 Mn 1.47 Mn - -2.76 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 14.80 Mn
Mar 31, 2026 -3.40 Mn
Dec 31, 2025 -13.60 Mn
Sep 30, 2025 -8.60 Mn
Jun 30, 2025 -330.30 Mn
Mar 31, 2025 -520.10 Mn
Dec 31, 2024 -55.60 Mn
Sep 30, 2024 -18.00 Mn
Jun 30, 2024 -50.90 Mn
Mar 31, 2024 -37.40 Mn
Dec 31, 2023 -24.00 Mn
Sep 30, 2023 10.30 Mn
Jun 30, 2023 31.60 Mn
Mar 31, 2023 14.10 Mn
Dec 31, 2022 14.30 Mn
Sep 30, 2022 68.90 Mn
Jun 30, 2022 71.20 Mn